Trial intelligence / Profile preview

Dysport vs Botox for Crow's Feet

NCT01529788Phase 4Completed

Sponsor
The Maas Clinic
Start
Sep 2009
Primary completion
Sep 2012
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of botulinum toxin type A in periorbital wrinkles, sponsored by The Maas Clinic. Primary endpoint: Time to onset of action at 6 days. Started Sep 2009; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

periorbital wrinkles

Beyond the preview

Go deeper on NCT01529788.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01529788.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call